Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 2 February 1996:
Vol. 271. no. 5249, pp. 659 - 662
DOI: 10.1126/science.271.5249.659
Prev | Table of Contents | Next

Reports

Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis

Li Mao,  Mark P. Schoenberg,  Marshall Scicchitano,  Yener S. Erozan,  Adrian Merlo,  Donna Schwab,  David Sidransky (1)

Microsatellite DNA markers have been widely used as a tool for the detection of loss of heterozygosity and genomic instability in primary tumors. In a blinded study, urine samples from 25 patients with suspicious bladder lesions that had been identified cystoscopically were analyzed by this molecular method and by conventional cytology. Microsatellite changes matching those in the tumor were detected in the urine sediment of 19 of the 20 patients (95 percent) who were diagnosed with bladder cancer, whereas urine cytology detected cancer cells in 9 of 18 (50 percent) of the samples. These results suggest that microsatellite analysis, which in principle can be performed at about one-third the cost of cytology, may be a useful addition to current screening methods for detecting bladder cancer.


L. Mao, M. Scicchitano, A. Merlo, D. Schwab, D. Sidransky, Department of Otolaryngology-Head and Neck Surgery, Division of Head and Neck Cancer Research, Johns Hopkins University School of Medicine, 818 Ross Research, 720 Rutland Avenue, Baltimore, MD 21205-2196, USA.
M. P. Schoenberg, Department of Urology, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Y. S. Erozan, Department of Pathology, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
(1) To whom correspondence should be addressed.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer.
M. Hanke, I. Kausch, G. Dahmen, D. Jocham, and J. M. Warnecke (2007)
Clin. Chem. 53, 2070-2077
   Abstract »    Full Text »    PDF »
Molecular Markers of Urothelial Cancer and Their Use in the Monitoring of Superficial Urothelial Cancer.
P. C. Black, G. A. Brown, and C. P. Dinney (2006)
J. Clin. Oncol. 24, 5528-5535
   Abstract »    Full Text »    PDF »
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection..
M. O. Hoque, S. Begum, O. Topaloglu, A. Chatterjee, E. Rosenbaum, W. Van Criekinge, W. H. Westra, M. Schoenberg, M. Zahurak, S. N. Goodman, et al. (2006)
J Natl Cancer Inst 98, 996-1004
   Abstract »    Full Text »    PDF »
TPMD: a database and resources of microsatellite marker genotyped in Taiwanese populations.
Y.-H. Chang, W.-H. Su, T.-C. Lee, H.-F. S. Sun, C.-H. Chen, W.-H. Pan, S.-F. Tsai, and Y.-S. Jou (2005)
Nucleic Acids Res. 33, D174-D177
   Abstract »    Full Text »    PDF »
Detection of Methylated Apoptosis-Associated Genes in Urine Sediments of Bladder Cancer Patients.
M. G. Friedrich, D. J. Weisenberger, J. C. Cheng, S. Chandrasoma, K. D. Siegmund, M. L. Gonzalgo, M. I. Toma, H. Huland, C. Yoo, Y. C. Tsai, et al. (2004)
Clin. Cancer Res. 10, 7457-7465
   Abstract »    Full Text »    PDF »
The Human MitoChip: A High-Throughput Sequencing Microarray for Mitochondrial Mutation Detection.
A. Maitra, Y. Cohen, S. E.D. Gillespie, E. Mambo, N. Fukushima, M. O. Hoque, N. Shah, M. Goggins, J. Califano, D. Sidransky, et al. (2004)
Genome Res. 14, 812-819
   Abstract »    Full Text »    PDF »
Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel.
E. Dulaimi, R. G. Uzzo, R. E. Greenberg, T. Al-Saleem, and P. Cairns (2004)
Clin. Cancer Res. 10, 1887-1893
   Abstract »    Full Text »    PDF »
High-Throughput Molecular Analysis of Urine Sediment for the Detection of Bladder Cancer by High-Density Single-Nucleotide Polymorphism Array.
M. O. Hoque, J. Lee, S. Begum, K. Yamashita, J. M. Engles, M. Schoenberg, W. H. Westra, and D. Sidransky (2003)
Cancer Res. 63, 5723-5726
   Abstract »    Full Text »    PDF »
Squamous Cell Carcinoma of the Esophagus Can Be Detected by Microsatellite Analysis in Tumor and Serum.
C. F. Eisenberger, W. T. Knoefel, M. Peiper, P. Merkert, E. F. Yekebas, P. Scheunemann, K. Steffani, N. H. Stoecklein, S. B. Hosch, and J. R. Izbicki (2003)
Clin. Cancer Res. 9, 4178-4183
   Abstract »    Full Text »    PDF »
Combined Microsatellite and FGFR3 Mutation Analysis Enables a Highly Sensitive Detection of Urothelial Cell Carcinoma in Voided Urine.
B. W. G. van Rhijn, I. Lurkin, D. K. Chopin, W. J. Kirkels, J.-P. Thiery, T. H. van der Kwast, F. Radvanyi, and E. C. Zwarthoff (2003)
Clin. Cancer Res. 9, 257-263
   Abstract »    Full Text »    PDF »
Loss of Heterozygosity Studies Revisited: Prior Quantification of the Amplifiable DNA Content of Archival Samples Improves Efficiency and Reliability.
K. Farrand, L. Jovanovic, B. Delahunt, B. McIver, I. D. Hay, N. L. Eberhardt, and S. K. G. Grebe (2002)
J. Mol. Diagn. 4, 150-158
   Abstract »    Full Text »    PDF »
Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
M. Wei, H. Wanibuchi, K. Morimura, S. Iwai, K. Yoshida, G. Endo, D. Nakae, and S. Fukushima (2002)
Carcinogenesis 23, 1387-1397
   Abstract »    Full Text »    PDF »
Deficiency of a novel mismatch repair activity in a bladder tumor cell line.
L. Gu, J. Wu, B.-B. Zhu, and G.-M. Li (2002)
Nucleic Acids Res. 30, 2758-2763
   Abstract »    Full Text »    PDF »
Prognostic Significance of Preoperative Molecular Serum Analysis in Renal Cancer.
M. L. Gonzalgo, C. F. Eisenberger, S. M. Lee, B. J. Trock, F. F. Marshall, S. Hortopan, D. Sidransky, and M. P. Schoenberg (2002)
Clin. Cancer Res. 8, 1878-1881
   Abstract »    Full Text »    PDF »
Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia.
J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al. (2002)
Clin. Cancer Res. 8, 314-346
   Abstract »    Full Text »    PDF »
Microsatellite Analysis of Free Tumor DNA in Urine, Serum, and Plasma of Patients: A Minimally Invasive Method for the Detection of Bladder Cancer.
M. Utting, W. Werner, R. Dahse, J. Schubert, and K. Junker (2002)
Clin. Cancer Res. 8, 35-40
   Abstract »    Full Text »    PDF »
Genetic Heterogeneity in Saliva from Patients with Oral Squamous Carcinomas: Implications in Molecular Diagnosis and Screening.
A. K. El-Naggar, L. Mao, G. Staerkel, M. M. Coombes, S. L. Tucker, M. A. Luna, G. L. Clayman, S. Lippman, and H. Goepfert (2001)
J. Mol. Diagn. 3, 164-170
   Abstract »    Full Text »    PDF »
Comprehensive Allelotyping of Human Intrahepatic Cholangiocarcinoma.
H. Momoi, H. Okabe, T. Kamikawa, S. Satoh, I. Ikai, M. Yamamoto, A. Nakagawara, Y. Shimahara, Y. Yamaoka, and M. Fukumoto (2001)
Clin. Cancer Res. 7, 2648-2655
   Abstract »    Full Text »    PDF »
Molecular Detection of Prostate Cancer in Urine by GSTP1 Hypermethylation.
P. Cairns, M. Esteller, J. G. Herman, M. Schoenberg, C. Jeronimo, M. Sanchez-Cespedes, N.-H. Chow, M. Grasso, L. Wu, W. B. Westra, et al. (2001)
Clin. Cancer Res. 7, 2727-2730
   Abstract »    Full Text »    PDF »
Allelic Losses in OraTest-directed Biopsies of Patients with Prior Upper Aerodigestive Tract Malignancy.
Z. Guo, K. Yamaguchi, M. Sanchez-Cespedes, W. H. Westra, W. M. Koch, and D. Sidransky (2001)
Clin. Cancer Res. 7, 1963-1968
   Abstract »    Full Text »    PDF »
Filling the Void: Urinary Markers for Bladder Cancer Risk and Diagnosis.
A. F. Gazdar and B. Czerniak (2001)
J Natl Cancer Inst 93, 413-414
   Full Text »    PDF »
Detection of Head and Neck Squamous Cell Carcinoma among Exfoliated Oral Mucosal Cells by Microsatellite Analysis.
M. F. Spafford, W. M. Koch, A. L. Reed, J. A. Califano, L. H. Xu, C. F. Eisenberger, L. Yip, P. L. Leong, L. Wu, S. X. Liu, et al. (2001)
Clin. Cancer Res. 7, 607-612
   Abstract »    Full Text »
Mechanisms underlying losses of heterozygosity in human colorectal cancers.
S. Thiagalingam, S. Laken, J. K. V. Willson, S. D. Markowitz, K. W. Kinzler, B. Vogelstein, and C. Lengauer (2001)
PNAS
   Abstract »    Full Text »
Promoter Hypermethylation Patterns of p16, O6-Methylguanine-DNA-methyltransferase, and Death-associated Protein Kinase in Tumors and Saliva of Head and Neck Cancer Patients.
S. L. B. Rosas, W. Koch, M. d. G. d. C. Carvalho, L. Wu, J. Califano, W. Westra, J. Jen, and D. Sidransky (2001)
Cancer Res. 61, 939-942
   Abstract »    Full Text »
Detecting Bladder Cancer in the Chinese by Microsatellite Analysis: Ethnic and Etiologic Considerations.
J. Zhang, Z. Fan, Y. Gao, Z. Xiao, C. Li, Q. An, and S. Cheng (2001)
J Natl Cancer Inst 93, 45-50
   Abstract »    Full Text »    PDF »
Fluorescent Methylation-specific Polymerase Chain Reaction for DNA-based Detection of Prostate Cancer in Bodily Fluids.
C. Goessl, H. Krause, M. Müller, R. Heicappell, M. Schrader, J. Sachsinger, and K. Miller (2000)
Cancer Res. 60, 5941-5945
   Abstract »    Full Text »
Molecular Assays for the Diagnosis of Minimal Residual Head-and-Neck Cancer: Methods, Reliability, Pitfalls, and Solutions.
V. M. M. van Houten, M. P. Tabor, M. W. M. van den Brekel, F. Denkers, R. G. A. Wishaupt, J. A. Kummer, G. B. Snow, and R. H. Brakenhoff (2000)
Clin. Cancer Res. 6, 3803-3816
   Abstract »    Full Text »
Loss of Heterozygosity Assay for Molecular Detection of Cancer Using Energy-transfer Primers and Capillary Array Electrophoresis.
I. L. Medintz, C.-C. R. Lee, W. W. Wong, K. Pirkola, D. Sidransky, and R. A. Mathies (2000)
Genome Res. 10, 1211-1218
   Abstract »    Full Text »
Genetic and Epigenetic Alterations in Normal Bladder Epithelium in Patients with Metachronous Bladder Cancer.
S. Muto, S. Horie, S. Takahashi, K. Tomita, and T. Kitamura (2000)
Cancer Res. 60, 4021-4025
   Abstract »    Full Text »
Evaluation of Microsatellite Analysis in Urine Sediment for Diagnosis of Bladder Cancer.
A. Schneider, S. Borgnat, H. Lang, O. Régine, V. Lindner, M. Kassem, C. Saussine, P. Oudet, D. Jacqmin, and M. P. Gaub (2000)
Cancer Res. 60, 4617-4622
   Abstract »    Full Text »
Microsatellite Instability at Selected Tetranucleotide Repeats Is Associated with p53 Mutations in Non-Small Cell Lung Cancer.
S. A. Ahrendt, P. A. Decker, K. Doffek, B. Wang, L. Xu, M. J. Demeure, J. Jen, and D. Sidransky (2000)
Cancer Res. 60, 2488-2491
   Abstract »    Full Text »
Perspectives on Surrogate End Points in the Development of Drugs that Reduce the Risk of Cancer.
G. J. Kelloff, C. C. Sigman, K. M. Johnson, C. W. Boone, P. Greenwald, J. A. Crowell, E. T. Hawk, and L. A. Doody (2000)
Cancer Epidemiol. Biomarkers Prev. 9, 127-137
   Abstract »    Full Text »
Diagnosis of Renal Cancer by Molecular Urinalysis.
C. F. Eisenberger, M. Schoenberg, C. Enger, S. Hortopan, S. Shah, N.-H. Chow, F. F. Marshall, and D. Sidransky (1999)
J Natl Cancer Inst 91, 2028-2032
   Abstract »    Full Text »    PDF »
Loss of Heterozygosity in Epithelial Cells Obtained by Bronchial Brushing: Clinical Utility in Lung Cancer.
C. A. Powell, S. Klares, G. O'Connor, and J. S. Brody (1999)
Clin. Cancer Res. 5, 2025-2034
   Abstract »    Full Text »    PDF »
Plasma DNA Microsatellites as Tumor-specific Markers and Indicators of Tumor Progression in Melanoma Patients.
Y. Fujiwara, D. D. J. Chi, H. Wang, P. Keleman, D. L. Morton, R. Turner, and D. S. B. Hoon (1999)
Cancer Res. 59, 1567-1571
   Abstract »    Full Text »    PDF »
Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer.
S. A. Ahrendt, J. T. Chow, L.-H. Xu, S. C. Yang, C. F. Eisenberger, M. Esteller, J. G. Herman, L. Wu, P. A. Decker, J. Jen, et al. (1999)
J Natl Cancer Inst 91, 332-339
   Abstract »    Full Text »    PDF »
Efficiency of Two Different Nine-Loci Short Tandem Repeat Systems for DNA Typing Purposes.
L. Sacchetti, G. Calcagno, I. Coto, N. Tinto, E. Vuttariello, and F. Salvatore (1999)
Clin. Chem. 45, 178-183
   Abstract »    Full Text »    PDF »
Relationship between Schistosomiasis and Bladder Cancer.
M. H. Mostafa, S. A. Sheweita, and P. J. O'Connor (1999)
Clin. Microbiol. Rev. 12, 97-111
   Abstract »    Full Text »    PDF »
Multiple Mutation Analyses in Single Tumor Cells with Improved Whole Genome Amplification.
W. Dietmaier, A. Hartmann, S. Wallinger, E. Heinmoller, T. Kerner, E. Endl, K.-W. Jauch, F. Hofstadter, and J. Ruschoff (1999)
Am. J. Pathol. 154, 83-95
   Abstract »    Full Text »    PDF »
Polymerase Chain Reaction-Based Microsatellite Polymorphism Analysis of Follicular and Hurthle Cell Neoplasms of the Thyroid.
D. L. Segev, M. Saji, G. S. Phillips, W. H. Westra, Y. Takiyama, S. Piantadosi, R. C. Smallridge, R. H. Nishiyama, R. Udelsman, and M. A. Zeiger (1998)
J. Clin. Endocrinol. Metab. 83, 2036-2042
   Abstract »    Full Text »
Science, medicine, and the future: Molecular assessment of cancer.
C. Caldas (1998)
BMJ 316, 1360-1363
   Full Text »
The Mutation Rate and Cancer.
A. L. Jackson and L. A. Loeb (1998)
Genetics 148, 1483-1490
   Abstract »    Full Text »    PDF »
Nucleic Acid-Based Methods for the Detection of Cancer.
D. Sidransky (1997)
Science 278, 1054-1058
   Abstract »    Full Text »
Oncology.
V. T. DeVita and A. B. Deisseroth (1996)
JAMA 275, 1833-1834
   Abstract »    PDF »
Mechanisms underlying losses of heterozygosity in human colorectal cancers.
S. Thiagalingam, S. Laken, J. K. V. Willson, S. D. Markowitz, K. W. Kinzler, B. Vogelstein, and C. Lengauer (2001)
PNAS 98, 2698-2702
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)